Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment

Please use this identifier to cite or link to this item: http://ir.sinica.edu.tw/handle/201000000A/88583

Title:	Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment
Authors:	Lin, HJ Liang, TL Chang, YY Liu, DZ Fan, JY Roffler, SR Lin, SY
Issue Date:	2022-06
Relation:	Pharmaceutics 14(6), 1202
URI:	http://ir.sinica.edu.tw/handle/201000000A/88583
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1999-4923&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	http://dx.doi.org/10.3390/pharmaceutics14061202
Appears in Collections:	生物醫學科學研究所

Show full item record

Check